Tarsus Pharmaceuticals (TARS) Amortizatization of Intangibles (2019 - 2026)

Tarsus Pharmaceuticals' Amortizatization of Intangibles history runs 8 years deep, the most recent figure standing at $849000.0 for Q1 2026.

• In Q1 2026, Amortizatization of Intangibles rose 253.75% year-over-year to $849000.0; the TTM figure through Mar 2026 stood at $1.5 million (up 132.81% YoY), while the FY2025 annual figure was $961000.0, up 92.2% from the prior year.
• Amortizatization of Intangibles was $849000.0 for Q1 2026 at Tarsus Pharmaceuticals, up from $241000.0 in the prior quarter.
• In the past five years, Amortizatization of Intangibles ranged from a high of $1.3 million in Q4 2022 to a low of $100000.0 in Q1 2024.
• Historically, Amortizatization of Intangibles has averaged $333727.3 across 5 years, with a median of $200000.0 in 2024.
• The sharpest annual moves came in 2022 and 2023: Amortizatization of Intangibles soared 347.62% in 2022, then tumbled 90.5% in 2023.
• A 5-year view of Amortizatization of Intangibles shows it stood at $1.3 million in 2022, then sank by 90.5% to $125000.0 in 2023, then jumped by 60.0% to $200000.0 in 2024, then gained by 20.5% to $241000.0 in 2025, then soared by 252.28% to $849000.0 in 2026.
• The last three Amortizatization of Intangibles figures came in at $849000.0 (Q1 2026), $241000.0 (Q4 2025), and $200000.0 (Q3 2025), per Business Quant data.